Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 millionInvivyd in vitro data showed continued ...
Tom Barrett, who is running for re-election in Michigan’s 7th Congressional District, shared in a wide-ranging interview on ...
Q1 2026 Earnings Call May 13, 2026 5:00 PM EDTCompany ParticipantsPing Rawson - Chief Financial OfficerJoseph Hazelton ...
Marty Makary is resigning as President Donald Trump's Food and Drug Administration head. The surgeon and health researcher's ...
Health Secretary Robert F. Kennedy Jr. has toned down his public criticism of vaccines, under orders from the White House.
Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for ...
For six years, Sen Ron Johnson (QAnon-Moscow) has been spewing the craziest anti-vaccine nonsense, especially regarding the ...
Food and Drug Administration commissioner’s decisions have hurt staff morale and put his job in crosshairs ...
As state leaders change laws to make vaccines more accessible, a coalition of doctors, public health advocates and everyday ...
Those who cheered ivermectin as a Covid-19 treatment, like Marjorie Taylor Greene, are now making unsubstantiated claims ...
Unlike Covid 19, hantavirus is no mystery Disease X. So how is it that the world has seemingly been caught off-guard by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results